Treatment of parkinsonism.
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001971:Bromocriptine / Q000627:therapeutic use*; D002230:Carbidopa / Q000627:therapeutic use; D004298:Dopamine / Q000031:analogs & derivatives; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004873:Ergolines; D011954:Receptors, Dopamine; D001971:Bromocriptine; D007980:Levodopa; D002230:Carbidopa; D004298:Dopamine